Companies: 10,795·Total market cap: $144.5T
MJardin Group, Inc.

MJardin Group, Inc.

MJARFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$90140
P/E Ratio
52W High$0.0001
52W Low$0.000001

MJardin Group, Inc. (MJARF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mjarf · pe ratio · data through Dec 31, 2020

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for MJardin Group, Inc. (MJARF) measures how much investors pay for each dollar of the company's trailing earnings. MJARF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.34.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2020-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.10
Based on 1 analyst
EPS (TTM)
-$0.34
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MJardin Group, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-15

PE Ratio History

2001 – 2020 · Annual
PE Ratio (TTM)
5Y Avg 359.5x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 5 fiscal years · Front-end computed
Average
359.5x
5-yr mean
Median
160.0x
5-yr midpoint
Minimum
33.2x
Lowest year
Maximum
823.9x
Highest year
33.2x
Min
Q1 · 25%160.0x
Median
Q3 · 75%823.9x
Max
Historically Low

At N/A, MJARF's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.

0th percentileHigher than 0 of 5 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
MJardin Group, Inc.
MJardin Group, Inc.You
MJARF
$0MN/A-$0.34
Allied Corp.
Allied Corp.
ALID
$0MN/A-$0.11
Applied Biosciences Corp.
Applied Biosciences Corp.
APPB
$0MN/A-$0.06
Target Group Inc.
Target Group Inc.
CBDY
$1MN/A-$0.00
Cann American Corp.
Cann American Corp.
CNNA
$1M0.19x$0.01
CannaPharmaRX, Inc.
CannaPharmaRX, Inc.
CPMD
$1MN/A-$0.02
James E. Wagner Cultivation Corporation
James E. Wagner Cultivation Corporation
JWCAF
$0MN/A-$0.08

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2020-12-31Latest
FY2020
$-0.34
2019-12-31
FY2019
$-3.27
2018-12-31
FY2018
$-2.07
2017-12-31
FY2017
33.15x$0.24
2016-08-31
FY2016
$-0.01
2015-08-31
FY2015
160.00x$0.05-80.6%
2014-08-31
FY2014
823.91x$0.01
2013-08-31
FY2013
$-0.01
2012-08-31
FY2012
$-0.01
2011-09-30
FY2011
$-0.02

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for MJardin Group, Inc. (MJARF) measures how much investors pay for each dollar of the company's trailing earnings. MJARF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.34.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.34 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MJARF pe ratio · 6 questions

MJARF's current PE ratio is N/A as of 2026-06-15, based on a stock price of $0.00 and TTM EPS of -$0.34. Data sourced from Financial Modeling Prep via MJARF's SEC 10-K and 10-Q filings.

MJARF PE ratioWhat is MJARF PE ratioCurrent PE ratio of MJARFMJARF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MJardin Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15